Live Breaking News & Updates on Ikarian Capital

Stay updated with breaking news from Ikarian capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 3.6%

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shot up 3.6% during mid-day trading on Thursday . The company traded as high as $24.05 and last traded at $23.86. 59,742 shares traded hands during trading, a decline of 62% from the average session volume of 159,164 shares. The stock had previously closed at $23.02. Wall […] ....

United States , Timothyp Noyes , Marinus Verwijs , Aerovate Therapeutics Inc , Wells Fargo Company , Jefferies Financial Group , Ikarian Capital , Securities Exchange Commission , Aerovate Therapeutics Company Profile , Vanguard Group Inc , Silverarc Capital Management , Swiss National Bank , Aerovate Therapeutics , Get Free Report , Exchange Commission , Point Capital , Capital Management , National Bank , Aerovate Therapeutics Daily ,

Verona Pharma (NASDAQ:VRNA) Shares Up 8.4%

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s share price rose 8.4% during mid-day trading on Wednesday . The stock traded as high as $14.56 and last traded at $14.49. Approximately 546,673 shares were traded during trading, a decline of 3% from the average daily volume of 565,092 shares. The stock had previously closed at […] ....

Verona Pharma , Kathleena Rickard , Piper Sandler , Hood River Capital Management , Bellevue Group , Virtu Financial , Janus Henderson Group , Ikarian Capital , Securities Exchange Commission , Get Free Report , Exchange Commission , Henderson Group , River Capital Management , Verona Pharma Daily ,

Veru (NASDAQ:VERU) Share Price Passes Above 200-Day Moving Average of $0.85

Veru Inc. (NASDAQ:VERU – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.85 and traded as high as $1.03. Veru shares last traded at $0.98, with a volume of 928,103 shares. Wall Street Analysts Forecast Growth A number of analysts […] ....

Mitchell Shuster Steiner , Raymond James , Cetera Advisors , Ikarian Capital , Veru Inc , Alpine Global Management , Securities Exchange Commission , Rosalind Advisors Inc , Veru Company Profile , Get Free Report , Shuster Steiner , Exchange Commission , Global Management , Rosalind Advisors , Veru Daily ,

Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Declines By 20.3%

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 83,100 shares, a drop of 20.3% from the April 30th total of 104,300 shares. Based on an average trading volume of 658,200 shares, the days-to-cover ratio is currently 0.1 […] ....

Acadian Asset Management , Ikarian Capital , Affinity Asset Advisors , Avalo Therapeutics Inc , Avalo Therapeutics , Get Free Report , Therapeutics Stock Down , Asset Management , Avalo Therapeutics Daily ,